Indeed, MERRF is categorized as one of the primary mitochondrial myopathies (PMM) (de Barcelos et al, 2019), a genetically defined group of disorders leading to defects of OXPHOS affecting predominantly skeletal muscle (Mancuso et al, 2017). This evidence concerns the gene MT-TK and Mitochondrial myopathy.